ACET - CIK 0001720580
The table below shows Adicet Bio, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $99.13M | $99.32M | $106.04M | $71.25M | $48.94M | $34.33M |
| SG&A | $22.99M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.29M |
| $26.53M |
| $26.30M |
| $22.22M |
| $22.76M |
| Operating income | -$122.11M | -$127.61M | -$152.04M | -$72.55M | -$61.43M | -$39.19M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | -$125.00K | -$2.81M |
| Net income | -$116.80M | -$117.12M | -$142.66M | -$69.79M | -$62.00M | -$36.68M |
| EPS (diluted) | -$16.95 | -$21.33 | -$3.31 | -$1.70 | -$2.00 | - |